Prime Medicine, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
ARCH Venture Management and affiliated funds updated their Schedule 13D filing for Prime Medicine, Inc., reflecting a slight decrease in their percentage ownership due to a recent public offering despite a new share purchase.